Defy Medical Alternatives: Costs, Care, and Switching

Defy Medical alternatives for testosterone replacement therapy (TRT) include Henry Meds, AlphaMD, TRT Nation, Hone Health, Male Excel, and local medical care. Henry Meds starts at $129 a month, but a lower advertised price is not a complete comparison. The best fit depends on why you're leaving, your future costs, testing, medication, state, and fertility plans.¹²

This page is for you if you're already a Defy patient — or were about to be — and you've decided to look elsewhere over the bill, the paperwork, the wait, or the treatment format.

This page is not for you if you've never had your testosterone tested, you're still deciding whether TRT is right at all, or fertility is your main concern. Those are different decisions, and we point you to the right ones below.

Last verified September 2026 · Public sources checked September 15, 2026 · By TRT Provider Guide · Editorial research — this version has not been medically reviewed.

Educational information, not medical advice. This comparison does not diagnose low testosterone or determine whether a prescription is appropriate.

Disclosure: Male Excel and Taurus Meds are commercial partners of TRT Provider Guide. We may earn commissions from qualifying referrals. This article uses internal guides and direct source links, not tracked enrollment links. Commercial relationships do not decide our conclusions. Read our affiliate disclosure.

What do Defy Medical alternatives cost over twelve months?

The figures below separate advertised plan prices from estimates and incomplete subtotals. They do not buy identical care, and none should replace an itemized quote for your own treatment plan.

How we built this table. We multiplied published monthly rates by twelve, added verified one-time charges where shown, and identified missing costs. We did not assume that a starter test covers all testing, that a vial lasts a month, or that a prepaid plan charges monthly. These are provider-stated offers and our calculations, not patient invoices or rankings of clinical quality.

Two honest notes on this table. First, a “monthly” price is not always a monthly payment. Annual prepayment, 60-day supplies, and minimum purchase periods change when cash leaves your account. Second, an advertised number is a starting price, not your quote. The exact prescription and services can change the bill.

Don't cancel Defy because another row has a smaller number. Compare what you would spend from today forward, including the costs that are still blank. The stay-or-switch worksheet below gives you one place to do that.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

Verification here means checking what the sources support. A published offer is not proof of the care, price, or prescription an individual patient will receive.

Wait — is Defy necessarily the expensive one?

Not necessarily. Defy's published average is an illustration, while a competing clinic's starting price may leave out testing, medication, or required fees; your actual future bills decide the comparison.

Defy's official cost FAQ gives an estimate of under $175 per month for the first year and around $125 per month afterward. Annualizing those figures gives under $2,100 and around $1,500. The available official excerpt describes an example, not a price every patient pays.⁹

The practical distinction matters more than a headline about a price change: a lower published average does not prove that your own charges fell. Nor does a lower competitor starting price prove that leaving saves money.

Ask them to itemise the actual treatment plan behind the average. If another medicine is being proposed, ask why, whether it is included, and what it adds to the bill. An average is an illustration. It is not your quote.

Defy advertises no membership fee or subscription contract for its TRT service. That does not erase agreed charges, appointment rules, or the need for ongoing care.¹⁰

One more correction to a common assumption: being able to submit paperwork to an insurer does not mean Defy accepts insurance. Its current terms say it does not accept insurance, can provide a receipt or superbill, and does not process or assist with claims. Reimbursement is not guaranteed.¹⁶

Why isn't the pharmacy price the cost of care?

A medication-only price leaves out the evaluation, tests, prescribing, and follow-up that a care program may provide. Compare those services separately before deciding whether a clinic's markup buys something you need.

Read that again, because it changes what you're actually shopping for.

When a clinic quotes a monthly program price, you're not buying only a medicine. You're paying for an evaluation, access to a prescriber, someone to review your bloodwork, and follow-up. Those services matter. Ask what access you get, who provides it, and what happens when you need help between visits.

But it means the question isn't "which alternative is cheapest." It's "how much care do I actually need, and who is competent to give it to me."

There's also a catch when comparing vial prices. You cannot divide the amount in a multidose vial by a weekly amount and assume it is usable for that whole period. CDC guidance says an opened multidose vial generally should be discarded after 28 days unless its manufacturer specifies a different period. Ask the dispensing pharmacist about the exact product's storage and discard instructions.¹⁷

Can you take a Defy prescription to your local pharmacy?

Defy's terms say it does not send controlled-substance prescriptions to retail pharmacies across state lines. That is Defy's stated policy, not a blanket ban on every telemedicine clinician using a local pharmacy.¹⁶

AlphaMD's terms, for example, describe partner-pharmacy fulfillment and, in some programs and locations, use of a pharmacy the patient chooses. That is not a promise that your particular testosterone prescription qualifies; ask before paying.¹⁸

Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. Prescribing and dispensing must meet applicable federal and state requirements.¹⁹²⁰²¹

If using your own pharmacy matters to you, price that care route directly. Ask a local clinician—or a telehealth practice that explicitly supports it—whether it can manage your care and send the appropriate prescription there. Compare online and local care rather than assuming every online brand works the same way.

Run your own numbers → Jump to the stay-or-switch worksheet

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

The tool is educational and non-diagnostic. It does not decide whether you qualify for treatment.

Do you need an outside physical exam before starting with Defy?

Defy's new-patient information requires a recent physical exam as well as laboratory work and health-history paperwork. Its FAQ describes a physical within six months of the first consultation; ongoing requirements depend on its current terms and your documented care plan.¹¹²²¹⁶

For some readers, this is the thing. Not the price — the paperwork.

If you already have a recent physical, ask whether Defy accepts that record. If you do not have one, an appointment with another practitioner can add a visit, a charge, and a delay before intake is complete. Get the exact requirements before booking or paying for another exam.

There's a version-drift detail worth knowing too. Defy's current Terms of Service, effective April 2, 2026, describe a physical-exam form at least every 24 months, unless the care plan specifies otherwise. An older patient-portal terms page says 12 months. Ask which requirement applies to your treatment plan.¹⁶²³

Now here's the part that cuts both ways. An outside physical can add useful information, but the paperwork burden is real. The requirement alone does not prove that Defy's care is better—or that another clinic's process is inadequate.

If you're reading this page because a clinic told you to get a physical you didn't expect to need, that is a legitimate reason to compare another provider's intake process. It really is. It is not a reason to skip an examination your clinician says you need.

Male Excel describes a home-based start: a $99 blood-collection kit and provider consultation, with results typically back about five business days after the laboratory receives the kit. Its own disclosures also say DEA or state requirements can make an in-person exam necessary. “Starts from home” is not the same as “you will never need an in-person visit.”²⁴²⁵

Stuck at the front door? Read Male Excel's testing and care process →

Which alternative fixes your reason for leaving?

The fastest way to narrow the list is to name the one thing that made you start searching, then read that row. A lower price that doesn't solve your actual problem is not an upgrade.

If you're in either of the last two rows, close this page. Seriously. Not every search should end in a purchase, and we'd rather you got the right care than a commission. If you're somewhere in the middle and none of these rows is obviously you, Find My TRT Path can help you organize the care-route questions.

What do the lower headline prices leave out?

TRT Nation: Its initial lab charge is not a complete annual lab budget. The FAQ describes testing after the first ten weeks, then six months after that first follow-up, and annually afterward. Existing results and clinical needs can change your own schedule. Its refills also require a request; they are not automatic.⁶²⁷

AlphaMD: The $98 equivalent requires annual payment. The middle option is $109 a month equivalent, billed every six months; the $129 monthly option still has a three-month commitment. Its advertised starter kit does not establish that every follow-up test is free.³

Hone: Its September 10 membership page lists testosterone cypionate from $28 per vial, not per month. Do not turn that into twelve months of medication without the actual prescription, vial specifications, and refill schedule. Its September 4 testing page and newer membership page also disagree by $5 on at-lab confirmation.⁷⁸

Taurus: The $49/$149 offer is public, but its relationship to the separate fee in the terms needs a written answer. The offer also mixes incompatible treatment-format descriptions. Ask for the exact medicine, treatment format, dispensing pharmacy, full testing schedule, and amount payable before treating it as a comparable package.¹⁴¹⁵

Marek: Ask for a current itemized quote. We are not using a review site's range to call it the most expensive option or to recommend it for complex medical histories.

Who is Male Excel actually for, and who should walk away?

Male Excel is worth investigating for someone who values home testing and its stated ongoing provider access, and who accepts compounded testosterone and separate membership charges. Its injection-and-thyroid bundle produces a $2,727 twelve-month subtotal before shipping—not a complete first-year quote or a reason to choose it over appropriate lower-cost care.¹³²⁴

Let's do the damaging admission first, because you deserve it before the pitch.

Male Excel is not the cheapest advertised option on this page, and it isn't close. Two charges, not one: membership and medication. The injection bundle's subtotal is $1,179 above Henry's advertised compounded-program base, before Male Excel shipping. That is a difference between two advertised packages, not a measured difference in equivalent care.¹³¹

If the bill is your only problem with Defy, compare Henry Meds, AlphaMD, and TRT Nation before paying more for Male Excel. A commercial relationship is not a reason to skip a better-fitting option.

Here's why Male Excel is on this page anyway.

What the provider says its program includes:

• Unlimited support messaging and provider e-visits, with continuity through the same provider. Support-team access is not the same thing as an instant clinician response.
• Structured 60-day reviews and blood testing every six months as part of its described program. Your clinician can require other testing.
• Compounded testosterone injections or cream, plus separate oral non-testosterone options. Those are not three interchangeable TRT formats.
• A published switching pathway. It describes evaluating patients who come from other clinics; it does not guarantee acceptance of an existing prescription unchanged.²⁴²⁵

Male Excel also describes an approach that avoids estrogen blockers. That's a provider-stated approach—not proof that it works better or that a different clinician's plan is wrong. We'll come back to the question to ask.

Who should walk away from Male Excel's current offer:

• You live in one of the 11 states its FAQ lists as unavailable: Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire, Rhode Island. Confirm current availability with another provider or local practice rather than assuming it serves those states.²⁵
• You need the program to bill insurance. Male Excel says it does not accept insurance. Ask your plan administrator about any reimbursement from health savings or spending accounts; don't count that money before confirmation.²⁵
• You specifically want an FDA-approved testosterone product. Its compounded testosterone does not meet that requirement. Discuss an identified FDA-approved product with a prescriber instead.²⁵²⁸
• You don't need or don't want the quoted thyroid-medication bundle. Ask for a testosterone-only quote and the clinical reason for any additional medicine. Do not assume the bundle fits you.¹³

One more thing to get in writing. Male Excel's pricing page names clomiphene, while its TRT page also describes enclomiphene. Clomiphene contains two forms; enclomiphene is one of them. These names should not be treated as interchangeable, and neither medicine is testosterone.¹³²⁴²⁶

But it's your prescription. If you're considering the oral option, ask them in writing which medicine you'd be getting, and confirm the price rather than inferring it from another product's listing.

Does that trade-off sound like your situation? Compare Male Excel's full bill and exclusions →

Why ask about aromatase inhibitors before comparing price?

An aromatase inhibitor reduces the conversion of testosterone to estradiol, a form of estrogen. Whether one belongs in a treatment plan is a clinical decision; including or excluding it does not by itself establish better care.²⁹

Three published positions are worth distinguishing:

• Defy's cost example includes an aromatase inhibitor. An example does not prove that every patient receives one by default.⁹
• Male Excel describes an approach without estrogen blockers. We have not independently tested its clinical claims.²⁴
• Henry Meds says an aromatase inhibitor may be prescribed at no extra cost when appropriate.¹

Anastrozole, one such medicine, is not FDA-approved for treating low testosterone in men. Its approved uses concern breast cancer in postmenopausal women; use with TRT in men is off-label.²⁹

The evidence also needs context. A trial in older men found reduced spine bone density with anastrozole. A separate small trial in healthy men found reduced insulin sensitivity. Neither study proves what will happen to every person receiving it alongside TRT, but both are reasons not to assume an added medicine is harmless.³⁰³¹

Your clinician's judgment matters more than our opinion. But it gives you one very good question:

“Why would I need an aromatase inhibitor, what would you monitor, and what are the alternatives?”

The answer tells you more about the proposed care than a price list alone.

What does FDA-approved mean here, and what changed in June 2026?

FDA approval applies to the exact finished drug product, not to every preparation containing testosterone. Compounded drugs are not FDA-approved, and a request to change testosterone labeling does not automatically rewrite every product's current instructions.²⁸³²

Two categories, and they are not interchangeable:

FDA-approved means the FDA reviewed the finished product for safety and effectiveness and its manufacturing quality. Kyzatrex is an approved oral testosterone undecanoate product; testosterone cypionate is also available as an approved product, such as Depo-Testosterone. Ask for the exact manufacturer and product, not only the ingredient name.¹²³³

Compounded means a drug is prepared by combining, mixing, or changing ingredients rather than supplied as an FDA-approved finished product. FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounding can meet particular patient needs when applicable requirements are met; it does not establish equivalence to an approved drug.²⁸

Which pharmacy would dispense it?

Defy names APS Pharmacy, Empower Pharmacy, and Hallandale Pharmacy on its pharmacy-contact page. Male Excel's FAQ names AnazaoHealth and WellDyne. These are useful public disclosures; they do not establish which pharmacy will fill your prescription or independently verify each facility's current license and product quality.³⁴²⁵

Henry describes using FDA-approved products or preparations from 503(a) compounding pharmacies or 503(b) outsourcing facilities. Those categories describe different regulatory frameworks; they do not turn a compounded prescription into an FDA-approved drug.¹²⁸

Before paying for a program, ask whether the exact product and pharmacy can be identified in advance. After clinical review, confirm them against the prescription and dispensing label. If the provider cannot identify the product before intake, count that as an unresolved decision—not proof that it is unsafe or that it will meet your preference.

What did HHS announce on June 18?

On 18 June 2026, HHS announced that the FDA is requesting three updates to the prescribing information for testosterone replacement products, following a review of new clinical data:

1. Remove the limitation of use stating that safety and effectiveness in men with age-related low testosterone have not been established — language added back in 2015.
2. Update the prostate cancer risk information — the requested change would narrow the prostate-cancer contraindication to metastatic disease.
3. Revise the warnings on benign prostatic hyperplasia (enlarged prostate).³²

Requested changes are not proof that all labels have changed. The Kyzatrex label posted on DailyMed on September 2, 2026, revised August 2026, still contains an age-related limitation of use and a contraindication for known or suspected prostate cancer. The current label for the exact product remains the reference to discuss with the prescriber.¹²

This follows FDA's February 28, 2025 class-wide action to remove cardiovascular-risk language from boxed warnings and add or strengthen blood-pressure warnings.³⁵

The TRAVERSE trial behind the cardiovascular review studied 5,246 men aged 45–80 with confirmed low testosterone and cardiovascular disease or risk factors. It tested a particular testosterone gel—not every TRT preparation. The main comparison did not find a higher risk of heart attack, stroke, or death from cardiovascular causes than with placebo. But atrial fibrillation, a type of irregular heartbeat; acute kidney injury; and pulmonary embolism, a blood clot in the lungs, occurred more often in the testosterone group.³⁶

“The warning was narrowed” is not the same as “there's no risk.” A press release is not a personal clearance to start treatment or ignore a contraindication.

Will switching actually save you money? Use this worksheet

Compare the money you'd spend from today forward, not fees you've already paid. Add up both sides completely, or you don't have a real comparison.

If you're already with Defy, leave your sunk costs out of the math. An earlier consultation or test you have already paid for is not a new cost of staying. But required future visits, tests, exams, and medication still count.

So the honest comparison isn't “Defy's first-year estimate versus Henry's first-year price.” It's “what Defy will charge me over the next twelve months versus what a new clinic will charge me over the next twelve months.” Ask the receiving clinician which records can be used; do not assume everything must be repeated or that everything transfers.

That gap can be a lot smaller than the ads suggest. Sometimes switching costs more.

Fill this in with real numbers from both sides. Blanks are the whole point — a blank means you don't have a comparison yet, and you shouldn't pretend a missing cost is zero.

Record these separately. Do not add the upfront payment again if it is already included in the cost rows.

Two numbers matter, and they're different. Cash due over the next twelve months is what actually leaves your account — that includes a full annual prepayment if you take one. Annualised rate is what the advertising quotes. Don't confuse the two.

A 60-day medication supply is not exactly two calendar months. A minimum purchase can also pay for care or supplies extending beyond the comparison period. Use actual billing dates to calculate cash payments rather than inventing a calendar from the monthly equivalent.

Check the arithmetic before calling something cheaper

For TRT Nation, $99.99 × 12 + $129 = $1,328.88 buys an annualized treatment allowance plus only one lab panel. If your written plan requires three separately purchased $129 panels, that same model becomes $1,586.88. These are scenarios, not a promise of your testing schedule or actual payment dates.⁴⁵

For Male Excel's injection-and-thyroid example, $99 + 12 × ($99 + $120) = $2,727, before shipping and any other required charge. Without the initial $99, the same ongoing advertised components total $2,628. The cream bundle's corresponding subtotals are $2,871 and $2,772.¹³

For Taurus, $49 + 12 × $149 = $1,837 uses the offer alone. It does not resolve the separate fee provision. A fee per billing period cannot be annualized until the applicable billing period and any offer exception are confirmed.¹⁴¹⁵

Copy this and send it to any clinic you're considering

I'm comparing continued care with my current provider against transferring to your program. Please send a written estimate showing my first charge, my recurring charges, the required labs and visits, medication and shipping, the minimum commitment, and the exact cancellation deadline. Please also confirm which existing records you'll review, which clinician can see me in my state, the exact product and dispensing pharmacy if treatment is appropriate, and how care would be coordinated during a transfer. Please flag anything that can't be confirmed until after clinical review.

A clinic that answers that in writing is telling you something. So is one that won't.

If fertility is on the table, how does the decision change?

Testosterone taken from outside the body can suppress sperm production. If you're trying to conceive now or planning near-term fertility, a urologist, reproductive urologist, or fertility-aware endocrinologist is a better starting point than choosing a general program by price.²¹²

Spermatogenesis is your body making sperm. We're not going to promise you that TRT will cause infertility, that it won't, or that recovery happens on a schedule. Nobody can tell you that from a web page.

What we will say clearly: if children are a live question, sort that out with a clinician before you sort out a subscription.

And keep these categories straight, because marketing can blur them:

• hCG, clomiphene, and enclomiphene are not TRT. They are not testosterone replacement and are not interchangeable with one another.
• Compounded enclomiphene is not FDA-approved. FDA's 2022 review described enclomiphene as a drug substance without an approved U.S. drug product; do not mistake a compounded offer for an approved medicine.³⁷
• Clomiphene is FDA-approved for ovulatory dysfunction in women. Use in men is off-label, and a compounded clomiphene preparation is not itself an FDA-approved finished product.²⁶²⁸
• Some hCG products have approved male indications. Novarel, for example, includes selected cases of hypogonadotropic hypogonadism—low testosterone related to insufficient hormone signals. That is not a blanket approval or guarantee for preserving fertility during TRT.³⁸

None of these is “natural TRT.” None is risk-free. Nobody should promise you any of them protects your fertility.

If near-term fertility is central to your decision, stop comparing monthly prices and book a urologist or reproductive urologist. That's the correct next step, and no page on the internet — this one included — substitutes for it.

The TRT and fertility guide explains the care questions. Find My TRT Path can help organize your next-step questions; it does not assess your fertility or select a treatment.

What does the December 2026 telemedicine date mean for you?

DEA and HHS have extended certain controlled-substance telemedicine flexibilities through December 31, 2026. That can permit a qualifying testosterone prescription without a prior in-person examination, but only when the applicable federal and state requirements are met.²⁰

This isn't a countdown and we're not going to pretend it is. It is the current end date of a temporary rule, not a guarantee that your care must stop then—or that the same rules will continue afterward.

For testosterone under this flexibility, the relevant remote evaluation uses real-time audio and video. A questionnaire alone is not the exception. Your clinician still needs the required prescribing authority, and state law or your health needs may require in-person care.²⁰²¹

So here's the question to ask every clinic on your shortlist:

"If the federal telemedicine rule changes on 1 January 2027, what happens to my prescription — and do you have licensed providers or an in-person option in my state?"

Ask before handing over a year's payment. Don't infer an answer from “nationwide” marketing or from the fact that a website accepts your address.

Defy's outside physical-exam requirement is a separate issue. A physical performed by another practitioner does not automatically establish that every federal requirement for the prescribing clinician has been satisfied. Do not treat it as a guarantee against future changes.²⁰¹⁶

How do you coordinate a switch without a care gap?

The order matters more than the destination. Get your records, ask the receiving clinician what must be reviewed, and agree on the handoff before changing your care or billing arrangements; no fixed number of weeks guarantees a smooth transfer.

1. Download or request everything first. Lab results, consultation notes, your current prescriptions, and the monitoring plan. Your right to request records does not depend on continuing as a patient, although portal access is a separate matter.³⁹
2. Share your current medicines exactly as prescribed. Use the labels and records so the receiving clinician has the drug, concentration, directions, and other medicines—not a guess from memory. Do not change treatment to make an intake test look different.
3. Tell your current clinician about your remaining supply and intended transfer. Ask what a safe timeline looks like for your situation. There is no verified six-week buffer that works for every patient or clinic.
4. Ask what the new clinician needs before taking over. Existing tests may help, but the clinician must decide whether additional results or an examination are needed. TRT Nation, for example, describes possible acceptance of appropriate outside labs generally within 120 days.⁶
5. Ask two questions before you pay anything. What is my total charge in month one, and what recurs? And what exact product, in what formulation, from which pharmacy? Ask which answers depend on clinical review.
6. Coordinate the handoff between clinicians. Confirm who is responsible for treatment and refills during the transition. A shipment is not, by itself, a complete handoff. Be open with both clinicians about existing prescriptions rather than arranging uncoordinated duplicate supply.¹⁶
7. Understand that cancelling and getting a refund are two different things. Cancellation may stop a renewal without erasing an existing commitment. Henry's multi-month terms can leave a balance; TRT Nation publishes a no-refund/no-return policy. Read the plan terms, not just the headline.⁴⁰⁴¹²⁷
8. If a gap looks likely, contact your current clinician promptly. Ask for a clinical plan; do not assume a temporary prescription can or will be issued. Do not use an unregulated seller to fill the gap. Testosterone remains a prescription controlled medicine.¹⁹

Which lab costs and monitoring rules belong in the handoff?

Ask the receiving clinician to separate diagnostic confirmation from monitoring during treatment. Existing treatment can affect laboratory interpretation, so an untreated-patient screening checklist should not become instructions to stop treatment yourself.²

Ready to line up the details before you close the old arrangement? Copy the written transfer-and-cost request →

Still weighing three options? Map your care route with Find My TRT Path →

What did we actually verify?

This comparison checks public offers, policies, product labels, and official clinical and regulatory guidance. It is not a patient trial, a clinical-quality score, or proof that a provider will accept a particular patient.

What we actually verified — September 15, 2026

Provider-stated facts: We checked accessible pricing, service, FAQ, and policy pages for the programs discussed. These establish what a provider publishes, not that every patient receives the advertised service or price. The tables distinguish known charges from missing charges and show the calculations rather than calling incomplete subtotals complete bills.

Official medical and regulatory facts: We checked FDA information, current DailyMed product labels, DEA's telemedicine extension, HHS guidance, the Endocrine Society guideline, and the primary studies cited below. A drug label or a clinical guideline—not a clinic's marketing—supports those statements.

Editorial conclusions: The stay-or-switch framework is our judgment about how to compare the facts. A lower advertised base does not establish the cheapest complete care, a broader menu does not prove better clinical care, and inclusion here is not a blanket endorsement.

Customer-experience signals: We did not use anecdotes to establish complaint rates, medical outcomes, clinical quality, or provider policy. No review-count trend is being used to prove that a clinic is growing, safe, or free of legal problems.

What we could not confirm, said plainly:

• Defy's full current cost and new-patient FAQ pages could not be retrieved during this check. Their official indexed excerpts support the attributed estimate and six-month intake wording; the complete service page, current terms, older portal terms, and pharmacy page were accessible. We have not established a historical price reduction or a date when patients' charges changed.
• No complete individualized bill was available for every provider. Shipping, extra tests, product choice, and service requirements can leave a comparison unfinished. Marek's current complete package price was not established; Taurus's offer and fee terms need reconciliation.
• Public state lists are provider statements, not licensing audits. Male Excel's exclusions were checked against its FAQ. We did not verify each possible assigned clinician's license, DEA authority, appointment availability, or each dispensing pharmacy's license in every state.
• Male Excel's oral medicine is described inconsistently across its pages. We did not resolve that by guessing which page is older. Its named pharmacies are public disclosures, not confirmation of your eventual dispensing pharmacy.
• We have not used these services, opened patient accounts, tested support response times, or completed clinical intake. This is a public-source comparison, not a hands-on review. The linked decision tool's clinical limitations remain unchanged.

Our method is documented at How We Review TRT Providers. It separates verified facts, provider statements, customer-experience signals, and editorial conclusions without assigning a numeric medical score. Read our editorial standards for the publication rules.

Found a number that's changed? Tell us through our corrections process so the source can be checked again.

What else should you know before choosing a Defy alternative?

The remaining questions concern testing, bills, prescriptions, and whether another practice can meet your needs. Use these answers to finish the comparison rather than treating a low starting price as a recommendation to change care.

Is there a cheaper alternative to Defy Medical?

There may be, but no universal winner is established by the published figures. Compare the advertised bases in the first table against your actual future Defy charges, then add missing labs, shipping, and commitments. Local care can also be worth pricing; it is not automatically the cheapest.

Does Defy Medical take insurance?

No. Its current terms allow a detailed receipt or superbill on request but say it does not process or assist with insurance claims. Check benefits before relying on reimbursement.¹⁶

Do I need a physical exam to start with Defy Medical?

Defy's intake information calls for a recent physical; its official FAQ excerpt specifies within six months of the first consultation. The current terms use a 24-month ongoing interval unless the documented plan differs. Confirm the accepted form and timing before paying for another exam.¹¹²²¹⁶

Is Defy Medical legit, or is it shutting down?

Defy's public service and patient-information pages were active when checked. That establishes a public operating presence—not the absence of lawsuits, enforcement actions, or licensing issues. Verify the actual clinician and dispensing pharmacy through the relevant official boards; a review count does not replace that check.¹⁰

How do I cancel Defy Medical?

Ask Defy to confirm any appointments, outstanding orders, authorized recurring services, and remaining charges. Appointments cancelled less than 24 hours ahead may incur the full consultation fee; dispensed medication is not refundable under its terms. Coordinate the medical handoff separately from ending purchases.¹⁶

Can I use my existing Defy labs at a new clinic?

Possibly. TRT Nation says it may accept appropriate outside results generally within 120 days, subject to review. Other practices can set different requirements. Ask which results they need before buying another panel.⁶

Can I keep the same prescription when I switch?

Don't assume so. A receiving clinician has to review your case and decide independently whether to prescribe and what plan is appropriate. Paying a new clinic does not guarantee a prescription, and no questionnaire guarantees approval.¹

Does an included lab kit mean all my testing is covered?

Not necessarily. Ask which initial, confirmatory and follow-up tests the plan actually covers, which outside results they'll accept, and which additional tests create a separate charge. The testing table above shows why a starter kit and a full monitoring plan are different purchases.

Is compounded testosterone the same as the FDA-approved product?

No. Compounded preparations are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before marketing. Ask which exact product you would receive and from which pharmacy.²⁸

Can I use my own local pharmacy instead?

It depends on the practice, prescription, and location. Defy's out-of-state retail-pharmacy restriction is not universal: AlphaMD describes conditional pharmacy choice. Get confirmation for your own medicine and state rather than assuming all online providers either allow or prohibit it.¹⁶¹⁸

Which alternative is best if I want children?

If you're trying to conceive now or soon, arrange a fertility-aware clinical evaluation before starting or changing a testosterone program. The Endocrine Society recommends against starting testosterone therapy in men planning near-term fertility.²

Do any of these clinics take Medicare or Medicaid?

Do not assume that a cash-pay clinic will bill either program or that a superbill will make the service reimbursable. Ask your plan and the actual clinician, laboratory, and pharmacy which services they can bill and what you would owe. Choosing telehealth versus an office visit alone does not answer those questions.

How is low testosterone actually diagnosed?

The Endocrine Society guideline calls for compatible symptoms or signs plus consistently low testosterone, using accurate tests and appropriate reference ranges. It recommends confirming the result with repeat morning fasting testing and evaluating the cause. One number on one morning is not a diagnosis, and a quiz or calculator cannot replace that assessment.²

---

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

It helps organize your situation and the questions to ask before you pay anyone. It's educational and non-diagnostic. It doesn't confirm low testosterone, determine eligibility, or guarantee a prescription, and it doesn't replace a clinician.

Educational information, not medical advice. Don't use this page to start, stop or change any medication — a licensed clinician has to evaluate your situation. Chest pain or severe shortness of breath can be an emergency: call 911.

By TRT Provider Guide, the independent decision resource for testosterone replacement therapy care. TRT Provider Guide is not a clinic, pharmacy, laboratory, drug manufacturer, insurer, or medical practice.

---

Sources and verification dates

All sources below were checked September 15, 2026. Provider pages support attributed offers and policies, not independent proof of outcomes. Where complete page access was unavailable, that limit is identified.

Footnotes

1. Henry Meds, Testosterone Therapy. Compounded-program and Kyzatrex prices; inclusions; men's age criterion; California restriction for the Kyzatrex offer; conditional aromatase-inhibitor inclusion; multi-month cancellation wording. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰

2. Endocrine Society, Testosterone Therapy for Hypogonadism Guideline Resources. Diagnostic confirmation, accurate assays, repeat morning fasting testing, evaluation of cause, fertility, and conditions requiring special care. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

3. AlphaMD, Published plans and process. $98 annual-payment, $109 six-month-payment, and $129 monthly-payment equivalents; commitments; included medication and supplies; advertised initial testing kit. ↩ ↩² ↩³ ↩⁴

4. TRT Nation, Testosterone Therapy. Advertised rate, minimum purchase, inclusions, and California pricing qualification. ↩ ↩²

5. TRT Nation, Lab Orders. Published $129 TRT panel; laboratory options and panel contents. ↩ ↩²

6. TRT Nation, Frequently Asked Questions. Outside laboratory results, age criterion, and described follow-up schedule. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

7. Hone Health, Hone Plus Membership: Men's Hormone Optimization with Labs, updated September 10, 2026. $135 membership, $45 initial test, $45/$80 confirmatory options, medication billed separately, and injection price per vial. ↩ ↩²

8. Hone Health, Men's Plus: HRT Lab Testing Schedule for TRT Patients, updated September 4, 2026. Follow-up schedule and a $50 at-lab confirmation figure that differs from the later membership page. ↩ ↩² ↩³

9. Defy Medical, How much does TRT cost with Defy Medical? and Cost of TRT. Official indexed excerpts supplied the illustrative first-year and subsequent-year estimates; direct retrieval of the complete pages was unavailable. No historical price-change date was verified. ↩ ↩² ↩³

10. Defy Medical, Testosterone Replacement Therapy. Public service description and separate-service billing model. ↩ ↩² ↩³

11. Defy Medical, Get Started. New-patient requirements, including labs, health history, and a recent physical. ↩ ↩² ↩³

12. DailyMed, Kyzatrex—testosterone undecanoate capsule, label posted September 2, 2026; prescribing information revised August 2026. Approval information, indication, limitation of use, contraindications, blood-pressure warnings, and effects on spermatogenesis. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

13. Male Excel, Hormone Replacement Therapy Costs. Startup and membership charges; testosterone-and-thyroid bundles; separate shipping/handling; medication billing; oral-product naming. The displayed offer is not an individualized quote. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

14. Taurus Meds, $49 Testosterone Offer. $49 test/consultation and $149 treatment offer; fee and treatment-format language require clarification against the terms and the individual prescription. ↩ ↩² ↩³

15. Taurus Meds, Terms and Conditions. $17.99 per-billing-period fee provision unless otherwise stated. The applicable billing period and offer exception were not resolved. ↩ ↩² ↩³

16. Defy Medical, Terms of Service, effective April 2, 2026. Insurance; payment and refunds; clinical procedures; medication management; physical exams; follow-up testing; out-of-state retail-pharmacy policy. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹²

17. Centers for Disease Control and Prevention, Preventing Unsafe Injection Practices. Multidose-vial discard guidance and manufacturer-specific exceptions. ↩

18. AlphaMD, Terms and Conditions. Pharmacy choice is conditional on the program and location; billing, payment, and cancellation terms. ↩ ↩² ↩³

19. U.S. Drug Enforcement Administration, Drug Scheduling. Testosterone is listed as a Schedule III controlled substance. ↩ ↩²

20. U.S. Drug Enforcement Administration, DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care, December 31, 2025. Fourth temporary extension through December 31, 2026; qualifying audio-video care and continuing federal/state requirements. ↩ ↩² ↩³ ↩⁴

21. HHS Telehealth, Licensing Across State Lines. State-specific authority and patient-location considerations. ↩ ↩²

22. Defy Medical, How do I get started with Defy Medical?. Official indexed excerpt describes the six-month physical-exam requirement; the full FAQ could not be retrieved. ↩ ↩²

23. Defy Medical patient portal, Terms of Service. Older published physical-exam interval. Compared with the current April 2026 terms rather than treated as the controlling requirement. ↩

24. Male Excel, TRT Online. Provider-stated home-testing, care access, review and monitoring schedule, switching process, and treatment descriptions. Marketing efficacy claims were not adopted as medical evidence. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

25. Male Excel, Frequently Asked Questions. State exclusions, test turnaround estimate, insurance position, formulation descriptions, in-person qualifications, and named pharmacies. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

26. DailyMed, Clomid—clomiphene citrate tablet. Approved female indication and clomiphene's component isomers. Male use is off-label. ↩ ↩² ↩³

27. TRT Nation, Refund and Cancellation Policy. Refund restrictions, purchased-period responsibility, and refill requests. ↩ ↩²

28. U.S. Food and Drug Administration, Understanding the Risks of Compounded Drugs. Compounded products are not FDA-approved and are not reviewed before marketing in the same way as approved drugs. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

29. DailyMed, Arimidex—anastrozole tablet. Approved indications and aromatase inhibition. ↩ ↩²

30. Burnett-Bowie SM et al., Effects of Aromatase Inhibition on Bone Mineral Density and Bone Turnover in Older Men with Low Testosterone Levels, 2009. Trial findings are limited to the studied population and intervention. ↩

31. Gibb FW et al., Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men, 2016. Small primary study; not evidence of an identical effect in every TRT patient. ↩

32. U.S. Department of Health and Human Services, HHS Announces Requested Updates to Testosterone Therapy Product Labels, June 18, 2026. Requested changes are distinguished from the actual current product label. ↩ ↩²

33. Pfizer, Depo-Testosterone prescribing information. Identified testosterone cypionate product; indication and product-specific warnings. ↩

34. Defy Medical Store, Pharmacy Contact Information. Provider-published pharmacy names and contacts, not an independent pharmacy-license review. ↩

35. U.S. Food and Drug Administration, FDA Issues Class-Wide Labeling Changes for Testosterone Products, February 28, 2025. Cardiovascular boxed-warning changes and blood-pressure warnings. ↩

36. Lincoff AM et al., Cardiovascular Safety of Testosterone-Replacement Therapy, New England Journal of Medicine, 2023. TRAVERSE population, formulation, cardiovascular endpoint, and additional adverse-event findings. ↩

37. U.S. Food and Drug Administration, Pharmacy Compounding Advisory Committee briefing material, 2022, enclomiphene citrate section, PDF pages 53–54. Regulatory background; this is not approval of a compounded product. ↩

38. DailyMed, Novarel—chorionic gonadotropin. Selected male indications do not establish guaranteed fertility preservation during TRT. ↩

39. U.S. Department of Health and Human Services, Your Medical Records. Access to records held by covered providers; a records request is distinct from continued portal access. ↩

40. Henry Meds, Terms of Service. Renewal and cancellation conditions; applicable plan terms remain relevant. ↩

41. Henry Meds, Return, Refund, and Replacement Policy. Refund limitations and exceptions; cancellation is not a universal refund entitlement. ↩